Renin-angiotensin-aldosterone system (RAAS) inhibitor, Imidapril, Purity ≥98%

Synonym: 89371-37-9; Imidaprilum; Hipertene; Tanatril; (4S)-3-[(2S)-2-[[(2S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-1-methyl-2-oxoimidazolidine-4-carboxylic acid; Renin-angiotensin-aldosterone system (RAAS) inhibitor

MDL: MFCD00923828
CAS Number: 89371-37-9
Compound CID: 5464343

Product Size

10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Imidapril, soluble in DMSO, water and ethanol, is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of angiotensin-converting enzyme (ACE) by inhibiting endocrinology-hormones. The molecular weight of the compound is 405.44, and its molecular formula is C₂₀H₂₇N₃O₆.

Molecular Weight

405.44

Molecular Formula

C₂₀H₂₇N₃O₆

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Solubility

In vitro: DMSO: 76 mg/mL (171.98 mM); Water: 46 mg/mL (104.09 mM); Ethanol: 25 mg/mL (56.57 mM)

Identity

Confirmed by NMR/HPLC/MS.

Applications

Imidapril can be studied extensively for its potential therapeutic applications in the treatment of hypertension and heart failure, helping to improve cardiovascular outcomes.